Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF InhibitionHélène Salmon, Miriam Mérad, Judith Agudo et al.|Immunity|2016Cited by 1.2k
Injectable Hydrogels for Sustained Codelivery of Subunit Vaccines Enhance Humoral ImmunityGillie A. Roth, Eric A. Appel, Emily C. Gale et al.|ACS Central Science|2020Cited by 210
Transitional dendritic cells are distinct from conventional DC2 precursors and mediate proinflammatory antiviral responsesFernando Bandeira Sulczewski, Juliana Idoyaga|Nature Immunology|2023Cited by 84
Mass cytometry profiling of human dendritic cells in blood and tissuesMarcela Alcántara‐Hernández, Juliana Idoyaga|Nature Protocols|2021Cited by 11